[{"address1": "2265 Upper Middle Road East", "address2": "Suite 602", "city": "Oakville", "state": "ON", "zip": "L6H 0G5", "country": "Canada", "phone": "289 910 0850", "fax": "905 481 2394", "website": "https://www.cardiolrx.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product candidate is CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Mr. David G. Elsley MBA", "title": "President, CEO & Director", "fiscalYear": 2023, "totalPay": 527156, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher J. Waddick C.A., C.M.A., CPA, CMA, MBA", "title": "CFO, Corporate Secretary & Director", "fiscalYear": 2023, "totalPay": 207734, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bernard  Lim B.Sc.", "title": "Chief Operating Officer", "fiscalYear": 2023, "totalPay": 363534, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew Warwick Hamer M.D.", "age": 62, "title": "Chief Medical Officer & Head of Research & Development", "yearBorn": 1962, "fiscalYear": 2023, "totalPay": 526073, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Trevor  Burns", "title": "Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John A. Geddes BSCPT, MBA", "title": "Vice President of Corporate Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.3, "open": 1.3, "dayLow": 1.19, "dayHigh": 1.32, "regularMarketPreviousClose": 1.3, "regularMarketOpen": 1.3, "regularMarketDayLow": 1.19, "regularMarketDayHigh": 1.32, "payoutRatio": 0.0, "beta": 0.665, "forwardPE": -3.8548388, "volume": 177818, "regularMarketVolume": 177818, "averageVolume": 319332, "averageVolume10days": 287380, "averageDailyVolume10Day": 287380, "bid": 1.19, "ask": 1.2, "bidSize": 1, "askSize": 1, "marketCap": 98491184, "fiftyTwoWeekLow": 1.151, "fiftyTwoWeekHigh": 3.12, "fiftyDayAverage": 1.3282, "twoHundredDayAverage": 1.86725, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 90365416, "profitMargins": 0.0, "floatShares": 77722363, "sharesOutstanding": 81603400, "sharesShort": 1434366, "sharesShortPriorMonth": 1322872, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0176, "heldPercentInsiders": 0.04003, "heldPercentInstitutions": 0.11608, "shortRatio": 5.4, "shortPercentOfFloat": 0.0183, "impliedSharesOutstanding": 82419400, "bookValue": 0.149, "priceToBook": 8.020134, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -36136008, "trailingEps": -0.38, "forwardEps": -0.31, "enterpriseToEbitda": -2.367, "52WeekChange": -0.19753087, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 1.195, "targetHighPrice": 9.87224, "targetLowPrice": 7.8736176, "targetMeanPrice": 8.784909, "targetMedianPrice": 8.69689, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 15885018, "totalCashPerShare": 0.195, "ebitda": -38172776, "totalDebt": 165984, "quickRatio": 2.323, "currentRatio": 2.485, "debtToEquity": 1.591, "returnOnAssets": -0.7907, "returnOnEquity": -1.59533, "freeCashflow": -12152216, "operatingCashflow": -25932334, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "CRDL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NCM", "messageBoardId": "finmb_424954803", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -8.076916, "regularMarketPrice": 1.195, "marketState": "REGULAR", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1547562600000, "regularMarketChange": -0.1049999, "regularMarketDayRange": "1.19 - 1.32", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 319332, "fiftyTwoWeekLowChange": 0.04400003, "fiftyTwoWeekLowChangePercent": 0.03822765, "fiftyTwoWeekRange": "1.151 - 3.12", "fiftyTwoWeekHighChange": -1.9249998, "fiftyTwoWeekHighChangePercent": -0.61698717, "fiftyTwoWeekChangePercent": -19.753086, "earningsTimestampStart": 1743451200, "earningsTimestampEnd": 1743796800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.38, "epsForward": -0.31, "epsCurrentYear": -0.41, "priceEpsCurrentYear": -2.9146342, "fiftyDayAverageChange": -0.13319993, "fiftyDayAverageChangePercent": -0.10028605, "twoHundredDayAverageChange": -0.6722499, "twoHundredDayAverageChangePercent": -0.36002138, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-10", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1740168641, "shortName": "Cardiol Therapeutics Inc.", "longName": "Cardiol Therapeutics Inc.", "displayName": "Cardiol Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]